Walter M. Stadler to Bryostatins
This is a "connection" page, showing publications Walter M. Stadler has written about Bryostatins.
Connection Strength
0.068
-
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma. Invest New Drugs. 2006 Mar; 24(2):141-9.
Score: 0.068